| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Executive Officer
1 company
Joseph C Sardano is Chief Executive Officer at SRTS. Joseph C Sardano's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.8M at current prices.
Historically, Joseph C Sardano's trades have earned a strong insider score of 81/100 across 19 rated trades. Over a 12-month horizon, all 18 of those trades were profitable, with an average 12-month return of +48.9%.
The SRTS filings lean toward selling, a net 417,772 shares.
Joseph C Sardano has 26 Form 4 filings on record from November 2016 to August 2026, all as Chief Executive Officer at Sensus Healthcare (SRTS), 2016–2026.
The 48 reported transactions were 42 open-market sales and 6 open-market purchases.
Counted by filing, the open-market trades come to 5 purchases worth about $303K and 21 sales worth about $5.3M.
The largest open-market purchase was 25,000 shares of SRTS at an average $4.03 on November 18, 2025, about $101K.
The largest open-market sale was 158,412 shares of SRTS at an average $14.12 on August 11, 2022, about $2.2M. Twelve months later SRTS was down 76%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | SRTS Sensus Healthcare, Inc. | Chief Executive Officer | Buy | 20,000 | $3.02 | $60,486.00 | +1.7% | - | - | |
| Nov 18, 2025 | SRTS Sensus Healthcare, Inc. | Chief Executive Officer | Buy | 25,000 | $4.03 | $100,750.00 | +2.1% | -5.2% | - | |
| Sep 14, 2023 | SRTS Sensus Healthcare, Inc. | Chief Executive Officer | Buy | 10,000 | $2.88 | $28,773.00 | +0.9% | -26.6% | +110.7% | |
| Aug 8, 2023 | SRTS Sensus Healthcare, Inc. | Chief Executive Officer | Buy | 10,000 | $3.86 | $38,574.00 | +0.9% | -42.7% | +51.4% | |
| May 10, 2023 | SRTS Sensus Healthcare, Inc. | Chief Executive Officer | Buy | 25,000 | $2.99 | $74,791.33 | +2.2% | +33.0% | +29.6% | |
| Sep 7, 2022 | SRTS Sensus Healthcare, Inc. | Chief Executive Officer | Sell | 41,588 | $12.53 | $521,257.59 | -3.5% | -48.5% | -76.9% | |
| Aug 11, 2022 | SRTS Sensus Healthcare, Inc. | Chief Executive Officer | Sell | 158,412 | $14.12 | $2,237,478.46 | -11.9% | -45.8% | -76.1% | |
| Mar 11, 2022 | SRTS Sensus Healthcare, Inc. | Chief Executive Officer | Sell | 133,356 | $10.16 | $1,354,781.92 | -9.1% | -15.4% | -47.4% | |
| Dec 16, 2021 | SRTS Sensus Healthcare, Inc. | Chief Executive Officer | Sell | 24,227 | $7.00 | $169,638.50 | -1.6% | +51.5% | -6.4% | |
| Dec 14, 2021 | SRTS Sensus Healthcare, Inc. | Chief Executive Officer | Sell | 13,969 | $7.22 | $100,824.05 | -0.9% | +34.6% | -11.6% |